Lv5
1350 积分 2022-10-25 加入
Donanemab in Early Symptomatic Alzheimer Disease
16天前
已完结
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
19天前
已完结
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease
19天前
已完结
Donanemab in Early Symptomatic Alzheimer Disease
27天前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
27天前
已完结
The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial
27天前
已完结
Hereditary haemorrhagic telangiectasia
30天前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
2个月前
已完结
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease
4个月前
已完结
The role of Ligand-Binding Assay and LC–MS in the Bioanalysis of Complex Protein and Oligonucleotide Therapeutics
4个月前
已完结
皖公网安备34019202002308
